AnnEHaightMD

Clinical Trials

• Analysis of T-Cell Immune Reconstitution Following Allogeneic Hematopoietic BMT for Severe SCD Start of enrollment: 2005 Sep 01

  Completed

• SALT: Alternative Donor Bone Marrow and Cord Blood Transplantation for High Risk Sickle Cell Disease Start of enrollment: 2006 Jan 01

  Terminated

  Early Phase 1

• Stem Cell Related Donor Safety Study Start of enrollment: 2010 Jan 01

  Completed

• Chronic Graft-versus-Host Disease Treatment (BMT CTN 0801) Start of enrollment: 2010 Apr 01

  Completed

  Phase 2, Phase 3

• Natural History Study of SCID Disorders Start of enrollment: 2010 Sep 02

  Enrolling by invitation

• Patients Treated for SCID (1968-Present) Start of enrollment: 2011 May 15

  Enrolling by invitation

• A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs) Start of enrollment: 2011 Oct 01

  Recruiting

  Roles: Contact, Principal Investigator

• Curative Versus Disease-Modifying Therapies in Children With Severe Sickle Cell Disease Start of enrollment: 2005 May 01

  Completed

• MRD Testing Before and After Hematopoietic Cell Transplantation for Pediatric Acute Myeloid Leukemia Start of enrollment: 2011 Oct 01

  Completed

• Caspofungin Acetate, Fluconazole, or Voriconazole in Preventing Fungal Infections in Patients Following Donor Stem Cell Transplant Start of enrollment: 2013 Mar 21

  Completed

  Phase 3

• Busulfan, Cyclophosphamide, and Melphalan or Busulfan and Fludarabine Phosphate Before Donor Hematopoietic Cell Transplant in Treating Younger Patients With Juvenile Myelomonocytic Leukemia Start of enrollment: 2013 Jun 24

  Completed

  Phase 2

• Study to Assess the Safety and Efficacy of Brincidofovir in Treatment of Early Versus Late Adenovirus Infection Start of enrollment: 2014 Mar 01

  Completed

  Phase 3

• Early Human Leukocyte Antigen (HLA) Matched Sibling Hematopoietic Stem Cell Transplantation Start of enrollment: 2019 Mar 22

  Recruiting

  Phase 2

• Identifying Predictors of Poor Health-Related Quality-of-Life Among Pediatric Hematopoietic Stem Cell Donors Start of enrollment: 2019 Apr 03

  Active, not recruiting

  Roles: Contact, Principal Investigator

• Join now to see all